BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9565566)

  • 1. Human protein S cleavage and inactivation by coagulation factor Xa.
    Long GL; Lu D; Xie RL; Kalafatis M
    J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of protein S during the hemostatic response.
    Brinkman HJ; Mertens K; van Mourik JA
    J Thromb Haemost; 2005 Dec; 3(12):2712-20. PubMed ID: 16359509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein S binds to and inhibits factor Xa.
    Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Norstrøm EA; Tran S; Steen M; Dahlbäck B
    J Biol Chem; 2006 Oct; 281(42):31486-94. PubMed ID: 16935856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.
    Borgel D; Gaussem P; Garbay C; Bachelot-Loza C; Kaabache T; Liu WQ; Brohard-Bohn B; Le Bonniec B; Aiach M; Gandrille S
    Biochem J; 2001 Dec; 360(Pt 2):499-506. PubMed ID: 11716779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
    Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
    J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements.
    Heeb MJ; Griffin JH
    Blood Cells Mol Dis; 2002; 29(2):190-9. PubMed ID: 12490286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
    Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
    Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
    Donath MS; Lenting PJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va.
    Kojima Y; Heeb MJ; Gale AJ; Hackeng TM; Griffin JH
    J Biol Chem; 1998 Jun; 273(24):14900-5. PubMed ID: 9614093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a factor Xa-interactive site within residues 337-372 of the factor VIII heavy chain.
    Nogami K; Lapan KA; Zhou Q; Wakabayashi H; Fay PJ
    J Biol Chem; 2004 Apr; 279(16):15763-71. PubMed ID: 14764590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.